Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: A prospective cohort study

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Li, Zhenyu ^a   Wang, Hongxia ^a   Liu, Jian ^a   Chen, Bing ^a   Li, Guangping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCITONIN; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR; TREM1 PROTEIN, HUMAN;

ADULT; AGED; APACHE; AREA UNDER THE CURVE; ARTICLE; CLINICAL SEVERITY SCORE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENERAL PATHOLOGICAL PARAMETERS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ACCURACY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; BLOOD; METABOLISM; MULTIVARIATE ANALYSIS; TIME; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; ROC CURVE; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896845568     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/641039     Document Type: Article

References (29)

1. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947 (Pubitemid 32641789)
2. Bouchon A., Dietrich J., Colonna M., Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. Journal of Immunology 2000 164 10 4991 4995 2-s2.0-0034657890 (Pubitemid 30305166)
3. Gibot S., Cravoisy A., Levy B., Bene M.-C., Faure G., Bollaert P.-E., Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. The New England Journal of Medicine 2004 350 5 451 458 2-s2.0-1642499233 10.1056/NEJMoa031544 (Pubitemid 38133765)
4. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C., High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet 1993 341 8844 515 518 2-s2.0-0027466275 10.1016/0140-6736(93)90277-N (Pubitemid 23066085)
5. Clerico A., Recchia F. A., Passino C., Emdin M., Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. American Journal of Physiology-Heart and Circulatory Physiology 2006 290 1 H17 H29 2-s2.0-33644795655 10.1152/ajpheart.00684.2005
6. Lobo S. M. A., Lobo F. R. M., Bota D. P., Lopes-Ferreira F., Soliman H. M., Mélot C., Vincent J.-L., C-reactive protein levels correlate with mortality and organ failure in critically III patients. Chest 2003 123 6 2043 2049 2-s2.0-0037709770 10.1378/chest.123.6.2043 (Pubitemid 36706731)
7. Gibot S., Kolopp-Sarda M. N., Béné M. C., Cravoisy A., Levy B., Faure G. C., Bollaert P. E., Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Annals of Internal Medicine 2004 141 1 9 15
8. Phua J., Koay E. S. C., Zhang D., Lee K. H., How well do serum sTREM-1 measurements prognosticate in septic shock? Anaesthesia and Intensive Care 2008 36 5 654 658 2-s2.0-51849160411
9. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J.-L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B (Pubitemid 36444440)
10. Su L.-X., Feng L., Zhang J., Xiao Y.-J., Jia Y.-H., Yan P., Feng D., Xie L.-X., Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study. Critical Care 2011 15 5, article R250 2-s2.0-80054821049 10.1186/cc10508
11. Zhang J., She D., Feng D., Jia Y., Xie L., Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infectious Diseases 2011 11, article 53 2-s2.0-79952087636 10.1186/1471-2334-11-53
12. Jiyong J., Tiancha H., Wei C., Huahao S., Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Medicine 2009 35 4 587 595 2-s2.0-62949193447 10.1007/s00134-008-1333-z
13. Bopp C., Hofer S., Bouchon A., Zimmermann J. B., Martin E., Weigand M. A., Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. European Journal of Anaesthesiology 2009 26 6 504 507 2-s2.0-68849093438 10.1097/EJA.0b013e328329afca
14. Dahaba A. A., Metzler H., Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiologica 2009 75 7-8 447 452 2-s2.0-69149086176
15. Nakamura A., Wada H., Ikejiri M., Hatada T., Sakurai H., Matsushima Y., Nishioka J., Maruyama K., Isaji S., Takeda T., Nobori T., Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 2009 31 6 586 591 2-s2.0-68049106352 10.1097/SHK.0b013e31819716fa
16. Castelli G. P., Pognani C., Cita M., Paladini R., Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Critical Care Medicine 2009 37 6 1845 1849 2-s2.0-66449093196 10.1097/CCM.0b013e31819ffd5b
17. Clec'h C., Ferriere F., Karoubi P., Fosse J. P., Cupa M., Hoang P., Cohen Y., Diagnostic and prognostic value of procalcitonin in patients with septic shock. Critical Care Medicine 2004 32 5 1166 1169 2-s2.0-2442544541 10.1097/01.CCM.0000126263.00551.06 (Pubitemid 38620986)
18. Schneider C. P., Yilmaz Y., Kleespies A., Jauch K.-W., Hartl W. H., Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 2009 31 6 568 573 2-s2.0-68049085313 10.1097/SHK.0b013e318193cb52
19. Szakmany T., Molnar Z., Procalcitonin levels do not predict mortality following major abdominal surgery. Canadian Journal of Anesthesia 2003 50 10 1082 1083 2-s2.0-0942298832 (Pubitemid 38139580)
20. Wang F., Wu Y., Tang L., Zhu W., Chen F., Xu T., Bo L., Li J., Deng X., Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Critical Care 2012 16 3, article R74 1 12 2-s2.0-84860518979 10.1186/cc11331
21. Kotanidou A., Karsaliakos P., Tzanela M., Mavrou I., Kopterides P., Papadomichelakis E., Theodorakopoulou M., Botoula E., Tsangaris I., Lignos M., Ikonomidis I., Ilias I., Armaganidis A., Orfanos S. E., Dimopoulou I., Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock 2009 31 4 342 347 2-s2.0-64849113221 10.1097/SHK.0b013e31818635b6
22. Póvoa P., C-reactive protein: a valuable marker of sepsis. Intensive Care Medicine 2002 28 3 235 243 2-s2.0-0036120619 10.1007/s00134-002- 1209-6 (Pubitemid 34230643)
23. Reith H. B., Mittelkötter U., Wagner R., Thiede A., Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Medicine 2000 26 2 S165 S169 2-s2.0-0034072086 (Pubitemid 30186576)
24. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A., Comparison of procalcitonin and C-reactive protein as markers of sepsis. Critical Care Medicine 2003 31 6 1737 1741 2-s2.0-0038129417 10.1097/01.CCM.0000063440.19188.ED (Pubitemid 36714230)
25. Suárez-Santamaría M., Santolaria F., Pérez- Ramírez A., Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis. European Cytokine Network 2010 21 1 19 26 10.1684/ecn.2009.0185
26. Fraunberger P., Wang Y., Holler E., Parhofer K. G., Nagel D., Walli A. K., Seidel D., Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006 26 1 10 12 2-s2.0-33747169897 10.1097/01.shk.0000215319.06866.bd (Pubitemid 44296999)
27. Kawczyński P., Polakowska E., Plasma levels of C-reactive protein, procalcitonin, interleukin-6 and interleukin-10 in preterm neonates evaluated for nosocomial sepsis. Medical Science Monitor 2004 10 supplement 2 58 61
28. Schneider C. P., Yilmaz Y., Kleespies A., Jauch K.-W., Hartl W. H., Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 2009 31 6 568 573 2-s2.0-68049085313 10.1097/SHK.0b013e318193cb52
29. Kibe S., Adams K., Barlow G., Diagnostic and prognostic biomarkers of sepsis in critical care. Journal of Antimicrobial Chemotherapy 2011 66 supplement 2 ii33 ii40 2-s2.0-79952611907 10.1093/jac/dkq523